Abstract
Unlike the capsids of icosahedral viruses, retroviral capsids are pleomorphic, with variably curved, closed fullerene shells composed of ~250 hexamers and exactly 12 pentamers of the viral CA protein. Structures of CA oligomers have been difficult to obtain because the subunit-subunit interactions are inherently weak, and CA tends to spontaneously assemble into capsid-like particles. Guided by a cryoEM-based model of the hexagonal lattice of HIV-1 CA, we used a two-step biochemical strategy to obtain soluble CA hexamers and pentamers for crystallization. First, each oligomer was stabilized by engineering disulfide cross-links between the N-terminal domains of adjacent subunits. Second, the cross-linked oligomers were prevented from polymerizing into hyperstable, capsid-like structures by mutations that weakened the dimeric association between the C-terminal domains that link adjacent oligomers. The X-ray structures revealed that the oligomers are comprised of a fairly rigid, central symmetric ring of N-terminal domains encircled by mobile C-terminal domains. Assembly of the quasi-equivalent oligomers requires remarkably subtle rearrangements in inter-subunit quaternary bonding interactions, and appears to be controlled by an electrostatic switch that favors hexamers over pentamers. An atomic model of the complete HIV-1 capsid was then built using the fullerene cone as a template. Rigid-body rotations around two assembly interfaces are sufficient to generate the full range of continuously varying lattice curvature in the fullerene cone. The steps in determining this HIV-1 capsid atomic model exemplify how structural biology can be leveraged by the use of hybrid methods, a powerful approach for exploring the structure of pleomorphic macromolecular complexes.
Keywords: HIV-1 capsid, hybrid methods, engineered disulfide bonds, electron microscopy, X-ray crystallography
Introduction1; 2; 3
During the late stages of their replication cycle, retroviruses assemble as “immature” virions composed of 2000–4000 copies of the virally encoded Gag polyprotein, which are radially arranged, adherent to the inner leaflet of the viral membrane and closely associated as a hexagonal, paracrystalline lattice with a unit cell spacing of ~80 Å (Figure 1(b, d) 4; 5; 6; 7; 8. The HIV-1 Gag protein is composed of four independently folded domains that are demarcated by flexible regions (Figure 1(a)). The N-terminal domain of Gag corresponds to the mature MA protein 9; 10, which targets Gag to assembly sites at the plasma membrane and facilitates incorporation of the envelope glycoproteins into the assembling virion. MA is myristoylated and has a basic patch of amino acids that mediate attachment to the inner leaflet of the viral envelope 11; 12; 13; 14; 15; 16; 17; 18; 19; 20; 21; 22; 23. The mature CA protein is formed by independently folded N- terminal and C-terminal domains, designated as CANTD and CACTD, connected by a flexible linker24; 25; 26; 27. These domains mediate the Gag-Gag contacts in the immature shell and mature capsid. In addition, HIV-1 Gag, in particular, contains two spacer peptides, called SP1 and SP2, which respectively demarcate the CA/NC and NC/p6 domains. Residues at the CA/SP1 boundary have been predicted to adopt an α-helical secondary structure that participate in forming Gag-Gag contacts in the immature shell 28; 29; 30; 31; 32; 33. Analogous regions have been identified in biochemical and structural analyses of other orthoretroviruses 34; 35; 36, suggesting that structural roles of the CA/SP1 boundary residues are conserved. The NC protein contains two zinc fingers that bind the RNA genome37; 38; 39; 40. High-affinity NC-RNA interactions enable specific recognition and packaging of two copies of the genome, whereas low-affinity interactions promote Gag assembly 41; 42; 43. HIV-1 Gag contains an additional region at its C-terminus, called p6, which is specific to lentiviruses. The p6 sequence lacks a defined tertiary structure, but contains two peptide motifs (called “late domains”) that function as docking sites for the cellular ESCRT machinery 44, which facilitates the release of newly assembled virions from the cell surface 45; 46; 47; 48; 49. (Other orthoretroviral Gag proteins harbor late domains with equivalent functions, but at different positions in the Gag primary sequence.)
Figure 1.
Organization of immature and mature HIV-1 virions. (a) Schematic tertiary structural model of full-length HIV-1 Gag. Individual domains are in different colors and are labeled on the left. Schematic models of the (b) immature and (c) mature virions. Images of (d) immature and (e) mature virions preserved in vitreous ice. Modified and reprinted from 1 with permission from Elsevier.
Cleavage of the Gag polyprotein in “immature” retroviruses results in dramatic morphological changes that result in “mature” infectious particles
Concomitant with budding and release from an infected cell, virions undergo a process called “maturation,” during which the viral protease cleaves the Gag polyprotein into its component domains 50, resulting in dramatic morphological rearrangements 5; 6; 51; 52; 53; 54 (compare Figure 1(b) and (d) with (c) and (e)). Cleavage of Gag and assembly of the mature capsid are essential for infectivity. Consequently, understanding the mechanisms that guide maturation and assembly of the mature capsid not only provide insight into the design principles of retroviral capsids but may also provide clues for novel therapeutic strategies.
After Gag cleavage, MA remains associated with the viral membrane 5; 6. Gag cleavage disassembles the immature lattice and liberates the subunits of the mature capsid (the CA protein) from the central region of the Gag precursor. CA is the last mature protein to be released as a result of sequential processing of Gag’s proteolytic sites. The flexible linker between CANTD and CACTD is not cleaved by the viral protease, and ~1500 copies of CA oligomerize to form a closed “mature” capsid that surrounds NC/RNA complex.
Although a precise understanding of the molecular transformations that occur during maturation must await a high-resolution structure of the immature Gag lattice, deuterium exchange and mutagenesis studies indicate that the two CA domains (CANTD and CACTD) utilize the same or highly overlapping interfaces to mediate interactions in both the immature and mature lattices 55; 56; 57; 58. It is likely then that the tertiary structures of these two domains are largely preserved in the Gag polyprotein and mature CA, except for residues in the immediate vicinity of the proteolytic sites 30; 32; 59; 60.
Proteolytic cleavage at the N-terminal end of CA releases the protein from the upstream MA domain and results in refolding of the first 13 residues of HIV-1 CA from an extended conformation into a β-hairpin (Figure 2(c)). The β-hairpin is stabilized by a salt bridge between the new Pro1 imino group and a conserved acidic residue (Asp51 in HIV-1) 26; 61. Formation of the β-hairpin probably destabilizes the immature CANTD hexamer and facilitates proper juxtaposition of the adjacent domains in the mature hexamer conformation 60; 61; 62; 63. Interestingly, it appears that folding of the β-hairpin does not proceed immediately after cleavage of the MA/CA junction, but after the final proteolytic processing step at the CA/SP1 junction 58. Thus, cleavage at the CA C-terminus appears to be the dominant maturation switch. Indeed, mutagenesis of this region is particularly detrimental to capsid assembly and virus infectivity 28; 64; 65; 66. Proteolysis of the CA/SP1 junction is expected to unravel the putative helical bundle in this region that helps stabilize the immature lattice, and indeed, the last 11 residues of CA appear to be disordered in the mature capsid 67; 68.
Figure 2.

(a) Morphologies of representative mature capsids of different orthoretroviruses. Images and fullerene models of Moloney murine leukemia virus (Mo-MLV, a gammaretrovirus), Mason-Pfizer monkey virus (MPMV, a betaretrovirus), and HIV-1 (a lentivirus) are shown.1 In all cases, the capsids are organized as fullerene structures (b) that incorporate 12 pentamers (red) to close the curved hexagonal lattices. The CA N-terminal domain (CANTD) (c) and C-terminal domain (CACTD) (d) of various retroviruses have a conserved tertiary structure in spite of minimal sequence homology. Secondary structural elements are displayed in different colors. The NTD has an arrowhead shape, whereas the CTD is more globular.
Studies of other orthoretroviruses have revealed comparable structural switches at the CA termini. For example, folding of the β-hairpin during maturation appears to be a general switch, because N-terminal extensions shift the in vitro assembly phenotypes of HIV-1, RSV and MPMV CA proteins from mature-like particles to immature-like particles 61; 63; 69; 70. Interestingly, spacer peptides upstream of the CA domains of RSV and MPMV appear to make important protein-protein interactions in the immature lattice that are not present in HIV-1 71; 72; 73. The best-characterized example is the “p10” region immediately upstream of RSV CA, which folds into a helix and packs against the globular CANTD domain 74. This interaction is important for RSV Gag hexamerization and lattice assembly 72; 73. Assembly regions downstream of CA, which are analogous to the SP1 spacer in HIV-1, have also been identified in MLV, RSV and MPMV Gag, even though these proteins lack a bona fide spacer between their CA and NC domains 34; 35; 36. Indeed, pillar-like densities below the CACTD hexamer layer are also visible in cryotomographic reconstructions of immature MPMV and RSV particles, although the MPMV pillar appears much smaller than in either HIV-1 or RSV 35. These examples highlight both the degree of conservation in the assembly principles of orthoretroviruses and the structural/mechanistic variations that different viruses use to reach the same endpoint.
Mature retroviral capsids are pleomorphic and adopt multiple shapes
The mature capsids of orthoretroviruses adopt different preferred shapes, and are primarily cones in HIV-1 and lentiviruses, cylinders in betaretroviruses (e.g., MPMV), and polyhedral or “spherical” in others (e.g., RSV, MLV) 75 (Figure 2a). The various shapes are a consequence of the distribution of the pentamers within a curved hexagonal lattice: “spherical” capsids have the 12 pentamers distributed randomly, cylinders have 6 pentamers at each end of a tube, and cones have 5 pentamers at the narrow end and 7 at the wide end (Figure 2(b)) 53; 54; 76; 77.
The architecture of the mature capsid of HIV-1 can be described by the geometric principles of fullerene shells 78; 79; 80; 81. The body of the capsid is a cone-shaped two-dimensional lattice of CA hexamers. By analogy to quasi-equivalent icosahedral viruses, the hexagonal capsid lattice incorporates 12 pentamers to form a closed shell. The pentamers are also composed of CA, and are distributed asymmetrically across the capsid shell. Thus, the capsid itself is globally asymmetric even though it is composed of locally symmetric building blocks.
The CA N-terminal domain (CANTD) and C-terminal domain (CACTD) of various retroviruses have a conserved tertiary structure in spite of minimal sequence homology
The CANTD is an arrowhead shaped domain composed of seven α-helices (numbered 1–7) 26; 59; 60 (Figure 2(c)), and the CACTD is a globular domain composed of a short 310 helix, a highly conserved sheet-turn-helix element termed the major homology region (MHR), and four α-helices (numbered 8–11) 25; 30 (Figure 2(d)). The isolated CACTD is a dimer in solution 25; 82; 83, and high-resolution X-ray and NMR structures of the isolated CACTD dimer have identified at least two dimerization modes (side-by-side and domain-swapped, with at least 3 possible side-by-side configurations) 25; 30; 82; 83; 84.
Hybrid methods: visualizing the HIV capsid from all angles
As a result of the pleomorphic morphology and lack of icosahedral symmetry of retroviral capsids5; 6, it is not possible to crystallize intact capsids and determine their high-resolution structures by X-ray crystallography, as is the case for viruses that manifest strict icosahedral symmetry. Although full-length CA can be expressed and purified in milligram quantities, the flexible linker between CANTD and CACTD and the inherently weak interactions within CA hexamers have also thwarted 3D crystallization. In addition, expressed CA tends to spontaneously assemble into capsid-like particles, further confounding crystallization. A “divide and conquer” hybrid approach has therefore been used to gain insight into mechanisms of retroviral capsid assembly (Figure 3). For example, the individual CANTD and CACTD domains have been separately expressed and solved by X-ray crystallography and NMR spectroscopy (Figure 2(c) and (d)). Extensive mutagenesis, proteolysis and mass spectrometry studies have implicated specific residues that mediate assembly, which can be mapped onto the high-resolution structures of the CANTD and CACTD domains.
Figure 3.
Illustration of the “divide and conquer” hybrid approach to structure determination of irregularly-shaped supramolecular complexes, such as the mature HIV-1 capsid. A working atomic model (center) is a synthesis of information derived from a variety of biochemical, biophysical and computational methods. For pleomorphic HIV-1 capsids, the methods (moving clockwise) include biochemical results based on mutagenesis, proteolysis, mass spectrometry, etc., low-resolution (20–50 Å) maps derived by electron cryotomography of authentic virions, (c) intermediate resolution (9–20 Å) cryoEM density maps of in vitro assemblies with helical, icosahedral and 2D crystalline symmetry, atomic resolution (1.5–3.5 Å) NMR and X-ray structures of building blocks, and models based on geometric principles and computational analysis.
Electron cryomicroscopy and cryotomography of mature virions and capsids of HIV-1 53; 54; 85 and RSV 77 have revealed the overall dimensions and capsid morphologies and shown that the hexamer-to-hexamer spacing in the mature lattice is 90–100 Å 85. The mature CA hexamer is distinct from the immature Gag hexamer, and therefore the inter-subunit interactions mediated by CANTD and CACTD must rearrange during maturation.
To a large extent, our understanding of the quaternary interactions in the mature capsid is derived from analyses of in vitro model systems that are assembled from purified recombinant CA proteins 68; 86; 87; 88; 89; 90. These assemblies recapitulate the local symmetry of the building blocks but are also globally symmetric, and are thus more amenable to biochemical and structural analyses (Figure 4). For example, helical tubes composed of CA hexamers have provided low-resolution views of the hexagonal lattice 80; 83, intermediate-resolution two-dimensional crystals of the hexagonal CA lattice have revealed elements of secondary structure 68, and icosahedral assemblies of RSV CA allowed the first visualization of the CA pentamer 91; 92. Biochemical and mutagenesis experiments have established that these in vitro assemblies faithfully recapitulate the lattice interactions of CA subunits in mature capsids 55; 56; 61; 76; 88; 90. Docking of high-resolution structures of the CANTD and CACTD domains into the cryoEM maps has provided working atomic models that have enabled further mutagenesis to stabilize CA oligomers.
Figure 4.
Gallery of in vitro symmetric assemblies for analysis of pleomorphic retroviral capsids: images of helical tubes, two-dimensional hexagonal crystals, and icosahedral particles. 3D density maps derived by image reconstruction of HIV-1 CA helical tubes80, 2D crystals 68 and RSV icosahedral particles 91. Note that the RSV “spheres” have icosahedral symmetry, and fall into two classes: T=1, composed of 12 CA pentamers, and T=3, composed of 20 hexamers and 12 pentamers 91. Only the T=1 reconstruction is shown.
Disulfide cross-linking of CA guided by a cryoEM-based atomic model
Wild-type full-length HIV-1 CA assembles in vitro into cylinders with helical symmetry 80; 86. In contrast, a single point mutation, R18A, shifted the assembly phenotype into spheres, cones, and cylinders – the three mature capsid shapes observed in retrovirions76. Replacement of R18 with a large hydrophobic residue (i.e., Val, Ile, Leu, Phe) generated CA proteins that assembled predominantly as spheres 67; 68. By the use of sparse matrix crystallization conditions, a buffer was identified in which CA assembled as large spheres up to ~2.5 μm in diameter. When applied to a continuous carbon EM grid, these large spheres collapsed and flattened, and behaved as well-ordered 2D crystals, exhibiting diffraction beyond 10 Å resolution. Electron cryocrystallography yielded a 3D map of full-length HIV-1 CA with an in-plane resolution of 9.0 Å. Rods of density could be readily identified as α-helices and served as fiducials for docking high-resolution structures of the CANTD and CACTD. This cryoEM based model served as the basis for designing disulfide crosslinks to stabilize the CA hexamer.
Strategy for screening disulfide crosslinks using an in vitro assembly assay
A critical aspect of disulfide crosslinking of oligomeric complexes is the ability to detect crosslinks that interfere with formation of the native complex or the generation of spurious crosslinks resulting from disulfide exchange. As noted, CA assembles as long tubes in 1 M NaCl and near neutral pH that faithfully mimic the hexagonal portion of the HIV-1 capsid lattice 76; 80; 85; 86; 87; 88 (Figures 4 and 5). Within the assembled cylinders, one or more of the engineered cysteine pairs would be positioned optimally to form intermolecular disulfide bonds and, upon oxidation, create a covalently linked hexamer. Our expectation was that subsequent incubation at low ionic strength would release individual disulfide-bonded hexamers (Figure 5).
Figure 5.
Schematic representation of the disulfide crosslinking strategy to obtain soluble HIV-1 CA hexamers for 3D crystallization. The CANTD and CACTD are represented by the orange ovals and blue circles, respectively. Tubes assemble at high ionic strength, and disulfide crosslinks between adjacent CANTD domains (green lines) form under oxidizing conditions. Tubes assembled from wild type CA tubes disassemble at low ionic strength, but the crosslinked tubes were hyperstable. Therefore, two additional, destabilizing mutations were introduced at the CACTD dimer interface (red X’s), so that the crosslinked hexamers could be generated by incubating the tubes at low ionic strength. Note that the approach has an embedded functional check, because hexamer assembly proceeds through a well-validated assembly assay.
A two-step biochemical strategy for generating soluble CA hexamers and pentamers for X-ray crystallography
Guided by the cryoEM-based atomic model 68, a panel of cysteine mutants was selected using a distance filter of ≤ 6 Å between Cβ-Cβ atoms 62 (Figure 6(a)). Within the assembled tubes, if the cysteine pairs were at the appropriate distance and geometry, then they should spontaneously oxidize and form disulfide bonds. The assembly reactions were performed in a highly reducing assembly environment that discouraged formation of spuriously cross-linked species and promoted disulfide bonding only if the local geometry was favorable. Nonreducing SDS-PAGE gels demonstrated that several mutants migrated as ladders of cross-linked n-mers, with n=1–6, with minimal formation of higher molecular weight species (Figure 6(b)). This indicates that disulfide bond formation was being driven by the non-covalent intersubunit interactions within the assembled particles and not by random, nonspecific association of soluble protein, which would lead to higher molecular weight aggregates. As a negative control, the cysteine pair Q13C/E45C had an expected separation of ~10 Å, and indeed, this mutant migrated exclusively as monomers.
Figure 6.
Design of disulfide-stabilized HIV-1 CA hexamers guided by a cryoEM based atomic model. (a) Top view ribbon representation of the 18-helix barrel comprising the CANTD– CANTD hexamerization interactions, as seen in the cryoEM model (3dik) 67; 68. Each subunit is colored differently. The locations of residues mutated to cysteines are indicated by spheres and are labeled within a single interface (between the yellow and blue subunits). Residue pairs are connected by black lines (broken lines for the Q13/E45 negative control). The A14/E45 and A42/T54 residue pairs are colored red and blue, respectively. (b) Non-reducing SDS-PAGE profiles of assembly reactions of HIV-1 CA double-cysteine mutants. Lanes 1–9 are wild-type HIV-1 CA, Q13C/E45C, A14C/E45C, P17C/R18C, P17C/T19C, P17C/A22C, N21C/A22C, P38C/N57C, and A42C/T54C. Molecular mass markers are labeled on the left, and the positions of cross-linked n-mers are indicated on the right.
A construct with cysteine substitutions for A14 and E45 displayed almost complete formation of 6-mers. In fact, this mutant assembled into cylinders that were hyperstable and remained intact even at low ionic strength, which would normally disintegrate tubes formed by wild-type CA. Consequently, a second biochemical step was introduced to weaken the extended lattice while leaving the hexamer-stabilizing interfaces unchanged. This was accomplished by introducing two mutations (W184A and M185A) within helix 9, which forms the CACTD dimer interface 25; 55 (Figure 7(b)). Since the CACTD dimer interface does not directly stabilize the hexamer, the W184A and M185A mutations were not expected to affect formation of the cross-linked A14C/E45C hexamers. CA containing the mutations A14C/E45C/M184A/M185A could be isolated as a homogenous population of crosslinked hexamers, and two different crystal forms yielded high-resolution X-ray structures that faithfully matched the cryoEM density map (Figure 8(g)).
Figure 7.
Top view of one sheet of the hexagonal lattice of 3D CA crystals, which recapitulates the hexameric lattice of authentic capsids at its planar limit 67. The CANTD domains are colored orange, and the CACTD domains are blue. This view emphasizes that CACTD dimers link adjacent hexamers. (b) Two views of the CACTD dimers, indicating the positions of W184 and M185 in H9 that were mutated to weaken the dimer interactions in generating soluble hexamers.
Figure 8.
Assembly and analysis of two disulfide-bonded mutants of CA that form soluble hexamers 62: A14C/E45C/W184A/M185A (a, c, e) and A42C/T54C/W184A/M185A (b, d, f). (a, b) Negatively-stained EM images of tubes assembled by dialyzing 30 mg/mL protein in 50 mM Tris, pH 8, 1MNaCl, and 2mM βME. The scale bar represents 500 nm. (c, d) Non-reducing SDS-PAGE profile of cross-linked soluble hexamers of the two constructs. Molecular mass markers are labeled on the left, and the expected positions of cross-linked n-mers are indicated on the right. (e, f) Conformations of the engineered disulfide bonds. (e) Ball-and-stick representation of the A14C/E45C/W184A/M185A mutant, with the rest of the structure in ribbons. Green mesh shows omit mFo–DFc densities for the sulfur atoms contoured at 3σ. The omit map was obtained by setting the sulfur occupancies to zero, introducing random shifts to the remaining atoms (mean displacement = 0.5 Å), and refining the resulting model with simulated annealing. Note that the Cys14 and Cys45 sulfur density peaks have equal magnitude and are 100% oxidized. (f) Disulfide-bonded conformation of Cys42 and Cys54 in the A42C/T54C/W184A/M185A mutant. Note that the sulfur density for Cys54 is clear, whereas Cys42 is weaker and more diffuse. (g, h, i, j) Structure of the disulfide-stabilized HIV-1 CA hexamer. Top view (g) and side view (h) of the hexamer, with the CANTD colored in orange and the CACTD in blue. Helices are represented as ribbons. In (g), note the close correspondence between the X-ray structure and the cryoEM density map derived from analysis of 2D hexagonal CA crystals (gray-scale).68 Top view (i) and side view (j) of the hexamer, with each subunit in a different color. The red and blue spheres indicate the locations of the stabilizing Cys14/Cys45 and Cys42/Cys54 disulfides, respectively.
Due to the possibility of perturbation of the CA structure by introduction of the disulfide, we determined the X-ray structure of a second disulfide pair. Even though this mutant (A42C/T54C) showed incomplete formation of 6mers (Figures 6(b) and 8(d)), the structure could be refined to 1.9 Å resolution. Furthermore, the structures of the (A14C/E45C) and (A42C/T45C) mutants superimposed with a root-mean-square deviation of only 0.4 Å on equivalent backbone atoms. Given this near identity of the independent structures, the non-mutated portions were combined to generate an atomic resolution model for the native hexamer (Figure 8(h) and (j)).
Note that the N21C/A22C mutant displayed a strong pentamer band (Figures 6(b) and 9(b)), and by the same strategy as described above, the X-ray structure of the CA pentamer was solved at 2.5 Å resolution (Figure 9(c)–(f)).
Figure 9.
Assembly and analysis of a disulfide-bonded mutant of CA that forms soluble pentamers: P17C/T19C/W184A/M185A 94. (a) Negative-stain EM revealed spherical particles indicative of insertion of pentamers. (b) Non-reducing SDS-PAGE profile of cross-linked soluble pentamers. Molecular mass markers are labeled on the left, and the expected positions of cross-linked n-mers are indicated on the right. (c, d, e, f) Structure of the disulfide-stabilized HIV-1 CA pentamer. Top view (c) and side view (d) of the pentamer, with the CANTD colored in orange and the CACTD in blue. Helices are represented as ribbons. Top view (e) and side view (f) of the pentamer, with each subunit in a different color. The yellow spheres in ((c) indicate the locations of the stabilizing Cys21/Cys22 disulfide.
Helix-capping hydrogen bonds function as molecular pivots between the CANTD and CACTD domains and enable rigid-body rotations
In the assembled CA lattice, each CACTD domain packs against the CANTD domain from the adjacent subunit, via an intermolecular set of interactions called the NTD-CTD interface 56; 68; 93 (Figure 10). A critical feature of the NTD-CTD interface is that it contains a set of direct protein-protein hydrogen bonds, each of which is a helix capping interaction, and connects a flexible polar side chain in one domain with a helix terminus in the other domain 67; 94. These helix-capping hydrogen bonds act as molecular pivots for limited rigid-body rotations of CACTD relative to CANTD (indicated by red double-headed arrow in Figure 10(b)). In this manner, the NTD-CTD interface restricts the movement of the CACTD dimers relative to the CANTD rings. Each dimer can only rotate about a fixed axis that is approximately parallel to the plane of the ring, and this flexion allows each CANTD ring to adopt slightly different bite angles relative to its neighbors. The NTD-CTD interface therefore has the essential function of channeling the native flexibility of the CA protein into a mechanism for generating variable lattice curvature. This feature is common to the hexamer and pentamer, since an identical set of interactions is found in both capsomers 67; 94.
Figure 10.
Atomic details of the hexamerization interface 67. (a) Polar and water-mediated contacts. Selected side chains are shown explicitly and labeled. Green mesh shows unbiased FO-FC density contoured at +3σ. These were modeled as water molecules (magenta spheres) in the structure derived from hexagonal crystals. Putative hydrogen bonds are represented by yellow lines. Note that the region around the salt bridge between P1 and D51 (red asterisk), which forms only upon maturation of CA, is particularly water rich. These two residues coordinate water-mediated hydrogen bonds with H12, T48, and Q50. We speculate that the missing E45 side chain (mutated to cysteine in this construct) would participate in this network. (b), (c) and (d) display 13 crystallographically independent high-resolution structures. (b) Helix-capping hydrogen bonds at the CANTD-CACTD interface. Relevant side chains are shown explicitly and labeled. Hydrogen bonds are shown as yellow lines. The most critical of these caps appears to be R173 (to helix 3), since it is located in the middle of the hexamerization interface, and is conserved in 1668/1670 sequences in the Los Alamos HIV database, with the remaining two conservatively substituted with lysine. An intermolecular C cap for helix 7 in the blue protomer is not shown. The double-headed red arrow indicates the location of the CACTD dimer interface. The helix-capping residues shown in (b) act as pivot points for lever-like motions of the CACTD. Helix-capping hydrogen bonds at energetically favorable distances are maintained, while producing substantial linear displacements at distal regions of the domain. Hydrogen bonds are shown as yellow lines. Capping residues are shown in stick representation, as are side chains for Y145 and R162, which form a pi-cation stack that may be energetically significant (black asterisk). (c) and (d) display top and side views, respectively, of the CA hexamer.
The CANTD hexamer and pentamer are stabilized by 18 and 15 helix bundles, respectively
The CANTD hexamer is a 6-fold symmetric ring that is organized around an 18-helix barrel composed of the first three helices of each subunit 67; 68; 95 (Figure 8(g) and (i)). The quaternary organization of the CA NTD pentamer and hexamer are quite similar, and the pentamer subunits form a 5-fold symmetric ring organized around a 15-helix barrel 91; 92; 94 (Figures 9(c) and (e)).
Even though the packing angles between adjacent subunits are different in the hexamer and pentamer, the subunits in each oligomer display a similar 3-helix repeat unit – stabilized by essentially identical hydrophobic interactions 94 (Figure 11(c)). The repeating interaction is a 3-helix bundle formed by length-wise packing of helix 2 from one subunit against helices 1 and 3 of the adjacent subunit (Figure 11(a) and (b)). In HIV-1, the center of the 3-helix bundle contains a small hydrophobic core composed of aliphatic sidechains (Figure 11(c)), whereas interactions at the periphery are mediated by polar residues. Direct electrostatic protein-protein contacts are conspicuously absent, and essentially all the inter-subunit hydrogen bonds are bridged by water molecules 67.
Figure 11.
Quasi-equivalence in the pentameric and hexameric CANTD rings 94. Top views of the pentameric (a) and hexameric (b) CANTD rings, with each subunit in a different color. Subunits in the pentamer and hexamer are shown in darker and lighter shades, respectively. The angles subtended by adjacent domains are shown explicitly for the blue and orange subunits. One of the repeating three-helix units is outlined in black. (c) Close-up view of the pentameric and hexameric repeat units, superimposed on helices 1 and 3 of the blue subunit. The aliphatic residues that form a small hydrophobic core are shown explicitly and labeled. (d) The ‘rotation’ between adjacent subunits, in going from the hexamer to the pentamer. The approximate position of the rotation axis is indicated by the red dot. Note that this axis is parallel to neither the pentameric nor hexameric symmetry axes.
The CA hexamer and pentamer are quasiequivalent
Switching between the CANTD hexamer and pentamer follows the general model for quasi-equivalence as originally proposed by Caspar and Klug 96. Alternative packing of subunits in the two oligomers occurs by a simple rotation of adjacent subunits, about an axis that appears to coincide with the precise center of the 3-helix repeat unit 94 (Figure 11). Residues at the center of the 3-helix repeat unit can therefore maintain essentially the same hydrophobic packing interactions in both oligomers, and only subtle rearrangements in the hydrogen bonding interactions at the inner and outer rims of the CANTD rings are required.
ARG18 is functions as an electrostatic switch that disfavors pentamer formation
The energetic landscape of hexamer vs. pentamer assembly appears to be controlled by an electrostatic switch 91; 94. In the case of HIV-1 CA, an almost universally conserved arginine residue (Arg18) occupies an annulus at the centers of both the hexamer and pentamer (Figure 12(c) and (d)). Juxtaposition of like charges creates electrostatic repulsion, which is greater for the pentamer because the arginine residues are closer to each other in the 5-fold ring 94. Indeed, substitution of Arg18 with uncharged residues promotes pentamer formation in vitro 68; 76. Electrostatic destabilization of the pentamer is most probably counterbalanced by local assembly rules and cooperativity, such that a pentamer is integrated into the assembling capsid lattice only at a position where incorporation of a hexamer is incompatible with the local lattice curvature.
Figure 12.
Modeling of the pentameric declination (a, b) and ARG18 as an electrostatic switch that disfavors pentamer formation (c, d) 94. (a) The CACTD dimer mediates hexamer-hexamer and pentamer-hexamer interactions and spans two distinct inter-ring distances in a declination. (a) Geometric model of a declination (light blue), with a docked CA NTD pentamer (yellow) and two CANTD hexamers (orange). The distances that must be bridged by the CACTD dimer connectors are shown by the black double-headed arrows. (b) Comparison of the X-ray (1A43, blue) and NMR (2KOD, magenta) structures of the isolated, full-affinity CACTD dimer. Note that the structural variations occur at both the tertiary and quaternary levels, indicating that the CACTD dimer has a flexible architecture. The structures were superimposed on one subunit (left), to illustrate the differences in dimer dimensions and packing geometry. The black double-headed arrows indicate the center-to-center distances between the helix 8 pairs. The dyads are indicated by filled circles. (c) Arg18 (blue spheres) resides at the centers of the hexamer and pentamer is proposed to function as an electrostatic switch that governs the distribution of hexamers and pentamers. Note the closer proximity of Cα-Cα distances across opposite Arg18 residues in the pentamer (10.9 Å) versus the hexamer 16.5 Å). For comparison, a fully extended arginine sidechain is ~6.5 Å long (mtt180 rotamer). Densities for the Arg18 sidechains are not well defined for the pentamer. In the hexamer structures, the Arg18 sidechains also had poor density in 3H4E, but were defined in 3H47. It is likely that the guanidinium sidechains move to relieve electrostatic repulsion. However, the Arg18 residues in the pentamer should experience greater electrostatic repulsion and have less freedom of movement (due to steric constraints), compared to the hexamer.
CACTD domains form dimeric linkers between hexamers in the lattice
The CANTD hexamers and pentamers are linked into a continuous lattice by symmetric CACTD dimers (Figure 7), with side-by-side interacting subunits (i.e., not domain-swapped). The affinity of the mature HIV-1 CACTD dimer is measurable in solution, with a dissociation constant (Kd) of ~10−5 M 25; 83. Characterized CA proteins of other orthoretroviruses remain monomeric in solution 97; 98; 99, but also form analogous dimers under conditions that promote capsid assembly 100; 101. The CACTD dimer interface is mediated by symmetric packing of helix 9 across the dyad, and hydrophobic interactions between the 310 helix of one subunit and helix 9 of the other 25; 30; 83. The lattice-stabilizing dimer interface is the same as the solution dimer interface 68; 83, implying that the basic assembly unit of the mature capsid is composed of two CA subunits linked by CACTD.
Rigid-body rotation at the CACTD dimer interface
Biochemical and structural analyses also indicate that the CACTD domain is conformationally flexible 68; 82; 84; 102; 103; 104. For example, comparison of X-ray 25; 30 and NMR 83 structures of full-affinity CACTD dimers reveal slight variations in the structure of the dimerization helix, which occur at both the tertiary level (in terms of helix 9 packing against other helices in the same domain) and quaternary level (in terms of the helix 9 crossing angle across the dimer dyad) (Figure 12(b)). Flexibility of the CACTD dimer might have functional implications, since twisting at the dimer interface may also dictate lattice curvature (indicated by red double-headed arrows in Figure 10(b)) 68; 103. Indeed, computational modeling of the HIV-1 capsid suggests that proper formation of the pentameric declinations requires a flexible dimer interface 94.
A cryoEM reconstruction of helical tubes composed of HIV-1 CA hexamers indicates that adjacent CACTD domains surrounding the 3-fold axes of the hexagonal lattice may also interact via extended polar residues 83. This interaction is not observed in structures of flattened lattices of CA 68, and therefore appears to specifically stabilize subunit packing in a curved lattice. In the assembled capsid, it is likely that interactions across the 3-fold interface vary in response to different degrees of rotation at the NTD-CTD interface 67; 83; 91.
Rigid-body rotations around two assembly interfaces are sufficient to generate the full range of continuously varying lattice curvature in the fullerene cone
Having on hand a complete gallery of high-resolution structures of the building blocks allowed us to build an atomic model of the HIV-1 capsid using the fullerene cone as a template (Figure 13). A key characteristic of the HIV-1 fullerene cone capsid is that the curvature of the hexagonal CA lattice changes continuously 78; 80 (Figure 13(b)). This is most easily appreciated by considering the bite angle between adjacent hexamers. The bite angles change continuously, and range from around 135° between two hexamers connected to the same pentamer at the ends of the cone to around 180° in more flat regions at the body of the cone (Figure 13(c)).
Figure 13.
Assembly of an atomic model of the HIV-1 capsid relies on rigid body rotations around the CANTD-CACTD and CACTD-CACTD assembly interfaces 94. (a) The fullerene cone 78 is composed of ~250 hexamers (gray) and exactly 12 pentamers (red), which introduce sharp declinations to close the HIV-1 capsid. (b) A line of hexamers (red) connecting two declinations emphasizes the continuously varying curvature in the hexagonal lattice. (c) Graph of dihedral angles between hexamer planes as a function of cone dimension, as measured along the line of hexamers in (b). (d) A backbone-only model composed of 1,056 CA subunits. The hexamers, pentamers and dimers are colored orange, yellow and blue, respectively. As depicted in (b), the capsid displays a variably curved surface. In the body of the cone, curvature changes continually, which was modeled by subunit flexion at the CANTD–CACTD interface (Figure 10(b–d)). Pentamers (yellow) alter the trajectory of the hexagonal lattice and introduce regions of sharp curvature (that is, declinations). Our modeling suggests that formation of the declinations entails a flexible CACTD dimer. (e) Edge view of the capsid showing a line of connected rings with the CANTD hexamers colored orange, CANTD pentamers colored yellow and the CACTD dimers colored blue.
In our modeling, the NTD hexamers, NTD pentamers and CTD dimers were treated as rigid bodies. Within the body of the cone, the CA subunits were arranged on a hexagonal lattice with a unit cell spacing of ~93 Å. The full range of variable lattice curvature in this region could be modeled by introducing small rigid-body rotations across the NTD–CTD interfaces, as observed in the independent views of the CA hexamers observed in different crystal forms (Figure 9(b)), while keeping the NTD–NTD hexamerization and CTD–CTD dimerization interfaces constant (Figure 12(b) and (e)). The CA protein has the requisite flexibility for creating such a variably curved lattice, because the CANTD and CACTD domains are linked by a flexible stretch of 4 amino acid residues. Indeed, NMR analyses of full-length CA proteins in solution demonstrate that the two domains can rotate almost independently of each other 97; 98. In the assembled lattice, the relative orientations of the CANTD rings and CACTD dimers can also vary 67; 83; 91.
The lattice curvature is most pronounced at the insertion sites of the pentameric declinations (Figures 12(a) and 13(a)). In modeling the pentameric declinations, we found that the CTD dimers must span different distances when connecting hexamers to hexamers and hexamers to pentamers (Figure 12(a)). Surprisingly, these distances were in close correspondence to the dimensions of two independently determined X-ray and NMR CTD dimer structures (2KOD and 1A43) (Figure 12(b)). Although the structures were solved from slightly different protein constructs, both retained the dimerization affinity of full-length CA. However, each exhibited a distinct subunit packing geometry across the dimer dyad (Figure 12(b)). Therefore the 2KOD dimer was used to connect hexamers to hexamers, and the 1A43 dimer was used to connect hexamers to pentamers. Models wherein the NTD rings were connected by either dimer alone displayed significant backbone clashes (2KOD) or relatively large separations (1A43) between subunits surrounding the declinations (not shown). This suggests that rotation or slippage at the CTD–CTD interface may be a mechanistic element of capsid assembly.
It is remarkable that our simple modeling approach, which allowed just two types of rigid-body rotation between the building blocks, produced a fullerene model wherein essentially all the subunits displayed reasonable packing geometries. On the basis of this analysis, we concluded that CA assembly entails flexibility at both the NTD–CTD interface and the dimer interface to generate the constantly varying lattice curvature in the HIV-1 capsid 94.
Acknowledgments
Supported by grants from the U.S. National Institutes of Health (RO1-GM066087 and P50-GM082545). I am especially grateful to my colleagues Barbie K. Ganser-Pornillos, Owen Pornillos, Kelly A. Dryden and Wesley Sundquist for their exceedingly valuable contributions to our research program and this manuscript. Much of this review was abstracted from our previous articles 1; 2; 6; 62; 67; 68; 94. I thank Rebecca Craven and Alasdair Steven for generously supplying images for Figure 4 (RSV CA “spheres”). I apologize to colleagues whose work was not cited due to lack of space or inadvertent omission.
Abbreviations
- βME
β-mercaptoethanol
- 2D
two-dimensional
- 3D
three-dimensional
- CACTD
C-terminal domain of CA
- CANTD
N-terminal domain of CA
- cryoEM
electron cryomicroscopy
- HIV-1
human immunodeficiency virus type 1
- HTLV
human T-cell leukemia virus
- MLV
murine leukemia virus
- RSV
Rous sarcoma virus
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Ganser-Pornillos BK, Yeager M, Sundquist WI. The structural biology of HIV assembly. Curr Opin Struct Biol. 2008;18:203–17. doi: 10.1016/j.sbi.2008.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ganser-Pornillos BK, Yeager M, Pornillos O, Rossmann MGaR, VB, editors. Viral Molecular Machines. Springer; 2011. Assembly and Architecture of HIV. in press. [Google Scholar]
- 3.Goff S, Knipe David, Peter Howley AEDG, Lamb Robert, Martin Malcolm, Roizman Bernard, Straus Stephen. Retroviridae: The Retroviruses and Their Replication. Lippincott Williams & Wilkins; Philadelphia, PA: 2007. [Google Scholar]
- 4.Carlson LA, Briggs JA, Glass B, Riches JD, Simon MN, Johnson MC, Muller B, Grunewald K, Kräusslich HG. Three-dimensional analysis of budding sites and released virus suggests a revised model for HIV-1 morphogenesis. Cell Host Microbe. 2008;4:592–9. doi: 10.1016/j.chom.2008.10.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Fuller SD, Wilk T, Gowen BE, Kräusslich HG, Vogt VM. Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle. Curr Biol. 1997;7:729–38. doi: 10.1016/s0960-9822(06)00331-9. [DOI] [PubMed] [Google Scholar]
- 6.Yeager M, Wilson-Kubalek EM, Weiner SG, Brown PO, Rein A. Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms. Proc Natl Acad Sci U S A. 1998;95:7299–304. doi: 10.1073/pnas.95.13.7299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Briggs JA, Riches JD, Glass B, Bartonova V, Zanetti G, Kräusslich HG. Structure and assembly of immature HIV. Proc Natl Acad Sci U S A. 2009;106:11090–5. doi: 10.1073/pnas.0903535106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Wright ER, Schooler JB, Ding HJ, Kieffer C, Fillmore C, Sundquist WI, Jensen GJ. Electron cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells. EMBO J. 2007;26:2218–26. doi: 10.1038/sj.emboj.7601664. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Massiah MA, Starich MR, Paschall C, Summers MF, Christensen AM, Sundquist WI. Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J Mol Biol. 1994;244:198–223. doi: 10.1006/jmbi.1994.1719. [DOI] [PubMed] [Google Scholar]
- 10.Hill CP, Worthylake D, Bancroft DP, Christensen AM, Sundquist WI. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc Natl Acad Sci U S A. 1996;93:3099–104. doi: 10.1073/pnas.93.7.3099. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Göttlinger HG, Sodroski JG, Haseltine WA. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1989;86:5781–5. doi: 10.1073/pnas.86.15.5781. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Spearman P, Wang JJ, Vander Heyden N, Ratner L. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J Virol. 1994;68:3232–42. doi: 10.1128/jvi.68.5.3232-3242.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Zhou W, Parent LJ, Wills JW, Resh MD. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J Virol. 1994;68:2556–69. doi: 10.1128/jvi.68.4.2556-2569.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Spearman P, Horton R, Ratner L, Kuli-Zade I. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism. J Virol. 1997;71:6582–92. doi: 10.1128/jvi.71.9.6582-6592.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Paillart JC, Göttlinger HG. Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of Gag membrane targeting. J Virol. 1999;73:2604–12. doi: 10.1128/jvi.73.4.2604-2612.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Ono A, Demirov D, Freed EO. Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding. J Virol. 2000;74:5142–50. doi: 10.1128/jvi.74.11.5142-5150.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Tang C, Loeliger E, Luncsford P, Kinde I, Beckett D, Summers MF. Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc Natl Acad Sci U S A. 2004;101:517–22. doi: 10.1073/pnas.0305665101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Ono A, Ablan SD, Lockett SJ, Nagashima K, Freed EO. Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc Natl Acad Sci U S A. 2004;101:14889–94. doi: 10.1073/pnas.0405596101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Saad JS, Miller J, Tai J, Kim A, Ghanam RH, Summers MF. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc Natl Acad Sci U S A. 2006;103:11364–9. doi: 10.1073/pnas.0602818103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Li H, Dou J, Ding L, Spearman P. Myristoylation is required for human immunodeficiency virus type 1 Gag-Gag multimerization in mammalian cells. J Virol. 2007;81:12899–910. doi: 10.1128/JVI.01280-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Datta SAK, Zhao Z, Clark PK, Tarasov S, Alexandratos JN, Campbell SJ, Kvaratskhelia M, Lebowitz J, Rein A. Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switch. J Mol Biol. 2007;365:799–811. doi: 10.1016/j.jmb.2006.10.072. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Dalton AK, Ako-Adjei D, Murray PS, Murray D, Vogt VM. Electrostatic interactions drive membrane association of the human immunodeficiency virus type 1 Gag MA domain. J Virol. 2007;81:6434–45. doi: 10.1128/JVI.02757-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Dalton AK, Murray PS, Murray D, Vogt VM. Biochemical characterization of rous sarcoma virus MA protein interaction with membranes. J Virol. 2005;79:6227–38. doi: 10.1128/JVI.79.10.6227-6238.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Gamble TR, Vajdos FF, Yoo S, Worthylake DK, Houseweart M, Sundquist WI, Hill CP. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell. 1996;87:1285–94. doi: 10.1016/s0092-8674(00)81823-1. [DOI] [PubMed] [Google Scholar]
- 25.Gamble TR, Yoo S, Vajdos FF, von Schwedler UK, Worthylake DK, Wang H, McCutcheon JP, Sundquist WI, Hill CP. Structure of the carboxyl- terminal dimerization domain of the HIV-1 capsid protein. Science. 1997;278:849–53. doi: 10.1126/science.278.5339.849. [DOI] [PubMed] [Google Scholar]
- 26.Gitti RK, Lee BM, Walker J, Summers MF, Yoo S, Sundquist WI. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science. 1996;273:231–5. doi: 10.1126/science.273.5272.231. [DOI] [PubMed] [Google Scholar]
- 27.Momany C, Kovari LC, Prongay AJ, Keller W, Gitti RK, Lee BM, Gorbalenya AE, Tong L, McClure J, Ehrlich LS, Summers MF, Carter C, Rossmann MG. Crystal structure of dimeric HIV-1 capsid protein. Nat Struct Biol. 1996;3:763–70. doi: 10.1038/nsb0996-763. [DOI] [PubMed] [Google Scholar]
- 28.Kräusslich HG, Fäcke M, Heuser AM, Konvalinka J, Zentgraf H. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. J Virol. 1995;69:3407–19. doi: 10.1128/jvi.69.6.3407-3419.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Accola MA, Hoglund S, Göttlinger HG. A putative α-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly. J Virol. 1998;72:2072–8. doi: 10.1128/jvi.72.3.2072-2078.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Worthylake DK, Wang H, Yoo S, Sundquist WI, Hill CP. Structures of the HIV-1 capsid protein dimerization domain at 2.6 Å resolution. Acta Crystallogr D Biol Crystallogr. 1999;55:85–92. doi: 10.1107/S0907444998007689. [DOI] [PubMed] [Google Scholar]
- 31.Liang C, Hu J, Russell RS, Roldan A, Kleiman L, Wainberg MA. Characterization of a putative α-helix across the capsid-SP1 boundary that is critical for the multimerization of human immunodeficiency virus type 1 Gag. J Virol. 2002;76:11729–37. doi: 10.1128/JVI.76.22.11729-11737.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Newman JL, Butcher EW, Patel DT, Mikhaylenko Y, Summers MF. Flexibility in the P2 domain of the HIV-1 Gag polyprotein. Protein Sci. 2004;13:2101–7. doi: 10.1110/ps.04614804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Morellet N, Druillennec S, Lenoir C, Bouaziz S, Roques BP. Helical structure determined by NMR of the HIV-1 (345–392)Gag sequence, surrounding p2: implications for particle assembly and RNA packaging. Protein Sci. 2005;14:375–86. doi: 10.1110/ps.041087605. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Cheslock SR, Poon DTK, Fu W, Rhodes TD, Henderson LE, Nagashima K, McGrath CF, Hu WS. Charged assembly helix motif in murine leukemia virus capsid: an important region for virus assembly and particle size determination. J Virol. 2003;77:7058–66. doi: 10.1128/JVI.77.12.7058-7066.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.de Marco A, Davey NE, Ulbrich P, Phillips JM, Lux V, Riches JD, Fuzik T, Ruml T, Kräusslich HG, Vogt VM, Briggs JA. Conserved and variable features of Gag structure and arrangement in immature retrovirus particles. J Virol. 2010;84:11729–36. doi: 10.1128/JVI.01423-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Keller PW, Johnson MC, Vogt VM. Mutations in the spacer peptide and adjoining sequences in Rous sarcoma virus Gag lead to tubular budding. J Virol. 2008;82:6788–97. doi: 10.1128/JVI.00213-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Morellet N, Jullian N, De Rocquigny H, Maigret B, Darlix JL, Roques BP. Determination of the structure of the nucleocapsid protein NCp7 from the human immunodeficiency virus type 1 by 1H NMR. EMBO J. 1992;11:3059–65. doi: 10.1002/j.1460-2075.1992.tb05377.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Morellet N, de Rocquigny H, Mely Y, Jullian N, Demene H, Ottmann M, Gerard D, Darlix JL, Fournie-Zaluski MC, Roques BP. Conformational behaviour of the active and inactive forms of the nucleocapsid NCp7 of HIV-1 studied by 1H NMR. J Mol Biol. 1994;235:287–301. doi: 10.1016/s0022-2836(05)80033-6. [DOI] [PubMed] [Google Scholar]
- 39.South TL, Blake PR, Sowder RC, 3rd, Arthur LO, Henderson LE, Summers MF. The nucleocapsid protein isolated from HIV-1 particles binds zinc and forms retroviral-type zinc fingers. Biochemistry. 1990;29:7786–9. doi: 10.1021/bi00486a002. [DOI] [PubMed] [Google Scholar]
- 40.Summers MF, Henderson LE, Chance MR, Bess JW, Jr, South TL, Blake PR, Sagi I, Perez-Alvarado G, Sowder RC, 3rd, Hare DR, et al. Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1. Protein Sci. 1992;1:563–74. doi: 10.1002/pro.5560010502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Jouvenet N, Simon SM, Bieniasz PD. Imaging the interaction of HIV-1 genomes and Gag during assembly of individual viral particles. Proc Natl Acad Sci U S A. 2009;106:19114–9. doi: 10.1073/pnas.0907364106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Miyazaki Y, Garcia EL, King SR, Iyalla K, Loeliger K, Starck P, Syed S, Telesnitsky A, Summers MF. An RNA structural switch regulates diploid genome packaging by Moloney murine leukemia virus. J Mol Biol. 2010;396:141–52. doi: 10.1016/j.jmb.2009.11.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.D’Souza V, Summers MF. Structural basis for packaging the dimeric genome of Moloney murine leukaemia virus. Nature. 2004;431:586–90. doi: 10.1038/nature02944. [DOI] [PubMed] [Google Scholar]
- 44.Hurley JH, Emr SD. The ESCRT complexes: structure and mechanism of a membrane-trafficking network. Annu Rev Biophys Biomol Struct. 2006;35:277–98. doi: 10.1146/annurev.biophys.35.040405.102126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.VerPlank L, Bouamr F, LaGrassa TJ, Agresta B, Kikonyogo A, Leis J, Carter CA. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag) Proc Natl Acad Sci U S A. 2001;98:7724–9. doi: 10.1073/pnas.131059198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Garrus JE, von Schwedler UK, Pornillos O, Morham SG, Zavitz KH, Wang HE, Wettstein DA, Stray KM, Cote M, Rich RL, Myszka DG, Sundquist WI. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell. 2001;107:55–65. doi: 10.1016/s0092-8674(01)00506-2. [DOI] [PubMed] [Google Scholar]
- 47.Martin-Serrano J, Zang T, Bieniasz PD. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med. 2001;7:1313–9. doi: 10.1038/nm1201-1313. [DOI] [PubMed] [Google Scholar]
- 48.Pornillos O, Alam SL, Davis DR, Sundquist WI. Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein. Nat Struct Biol. 2002;9:812–7. doi: 10.1038/nsb856. [DOI] [PubMed] [Google Scholar]
- 49.Wollert T, Wunder C, Lippincott-Schwartz J, Hurley JH. Membrane scission by the ESCRT-III complex. Nature. 2009;458:172–7. doi: 10.1038/nature07836. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Pettit SC, Sheng N, Tritch R, Erickson-Viitanen S, Swanstrom R. The regulation of sequential processing of HIV-1 Gag by the viral protease. Adv Exp Med Biol. 1998;436:15–25. doi: 10.1007/978-1-4615-5373-1_2. [DOI] [PubMed] [Google Scholar]
- 51.Nermut MV, Frank H, Schafer W. Properties of mouse leukemia viruses. 3. Electron microscopic appearance as revealed after conventional preparation techniques as well as freeze-drying and freeze-etching. Virology. 1972;49:345–58. doi: 10.1016/0042-6822(72)90487-4. [DOI] [PubMed] [Google Scholar]
- 52.Yoshinaka Y, Luftig RB. Murine leukemia virus morphogenesis: cleavage of P70 in vitro can be accompanied by a shift from a concentrically coiled internal strand (“immature”) to a collapsed (“mature”) form of the virus core. Proc Natl Acad Sci U S A. 1977;74:3446–50. doi: 10.1073/pnas.74.8.3446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Briggs JA, Grünewald K, Glass B, Forster F, Kräusslich HG, Fuller SD. The mechanism of HIV-1 core assembly: insights from three-dimensional reconstructions of authentic virions. Structure. 2006;14:15–20. doi: 10.1016/j.str.2005.09.010. [DOI] [PubMed] [Google Scholar]
- 54.Benjamin J, Ganser-Pornillos BK, Tivol WF, Sundquist WI, Jensen GJ. Three-dimensional structure of HIV-1 virus-like particles by electron cryotomography. J Mol Biol. 2005;346:577–88. doi: 10.1016/j.jmb.2004.11.064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.von Schwedler UK, Stray KM, Garrus JE, Sundquist WI. Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J Virol. 2003;77:5439–50. doi: 10.1128/JVI.77.9.5439-5450.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Lanman J, Lam TT, Barnes S, Sakalian M, Emmett MR, Marshall AG, Prevelige PE., Jr Identification of novel interactions in HIV-1 capsid protein assembly by high-resolution mass spectrometry. J Mol Biol. 2003;325:759–72. doi: 10.1016/s0022-2836(02)01245-7. [DOI] [PubMed] [Google Scholar]
- 57.Lanman J, Lam TT, Emmett MR, Marshall AG, Sakalian M, Prevelige PE., Jr Key interactions in HIV-1 maturation identified by hydrogen-deuterium exchange. Nat Struct Mol Biol. 2004;11:676–7. doi: 10.1038/nsmb790. [DOI] [PubMed] [Google Scholar]
- 58.Monroe EB, Kang S, Kyere SK, Li R, Prevelige PE., Jr Hydrogen/deuterium exchange analysis of HIV-1 capsid assembly and maturation. Structure. 2010;18:1483–91. doi: 10.1016/j.str.2010.08.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Tang C, Ndassa Y, Summers MF. Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein. Nat Struct Biol. 2002;9:537–43. doi: 10.1038/nsb806. [DOI] [PubMed] [Google Scholar]
- 60.Kelly BN, Howard BR, Wang H, Robinson H, Sundquist WI, Hill CP. Implications for viral capsid assembly from crystal structures of HIV-1 Gag(1–278) and CA(N)(133–278) Biochemistry. 2006;45:11257–66. doi: 10.1021/bi060927x. [DOI] [PubMed] [Google Scholar]
- 61.von Schwedler UK, Stemmler TL, Klishko VY, Li S, Albertine KH, Davis DR, Sundquist WI. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J. 1998;17:1555–68. doi: 10.1093/emboj/17.6.1555. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Pornillos O, Ganser-Pornillos BK, Banumathi S, Hua Y, Yeager M. Disulfide bond stabilization of the hexameric capsomer of human immunodeficiency virus. J Mol Biol. 2010;401:985–95. doi: 10.1016/j.jmb.2010.06.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Gross I, Hohenberg H, Huckhagel C, Kräusslich HG. N-terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles. J Virol. 1998;72:4798–810. doi: 10.1128/jvi.72.6.4798-4810.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Gross I, Hohenberg H, Wilk T, Wiegers K, Grattinger M, Muller B, Fuller S, Kräusslich HG. A conformational switch controlling HIV-1 morphogenesis. EMBO J. 2000;19:103–13. doi: 10.1093/emboj/19.1.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Li F, Goila-Gaur R, Salzwedel K, Kilgore NR, Reddick M, Matallana C, Castillo A, Zoumplis D, Martin DE, Orenstein JM, Allaway GP, Freed EO, Wild CT. PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing. Proc Natl Acad Sci U S A. 2003;100:13555–60. doi: 10.1073/pnas.2234683100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Müller B, Anders M, Akiyama H, Welsch S, Glass B, Nikovics K, Clavel F, Tervo HM, Keppler OT, Kräusslich HG. HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity. J Biol Chem. 2009;284:29692–703. doi: 10.1074/jbc.M109.027144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Pornillos O, Ganser-Pornillos BK, Kelly BN, Hua Y, Whitby FG, Stout CD, Sundquist WI, Hill CP, Yeager M. X-ray structures of the hexameric building block of the HIV capsid. Cell. 2009;137:1282–92. doi: 10.1016/j.cell.2009.04.063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Ganser-Pornillos BK, Cheng A, Yeager M. Structure of full-length HIV-1 CA: a model for the mature capsid lattice. Cell. 2007;131:70–9. doi: 10.1016/j.cell.2007.08.018. [DOI] [PubMed] [Google Scholar]
- 69.Rumlova-Klikova M, Hunter E, Nermut MV, Pichova I, Ruml T. Analysis of Mason-Pfizer monkey virus Gag domains required for capsid assembly in bacteria: role of the N-terminal proline residue of CA in directing particle shape. J Virol. 2000;74:8452–9. doi: 10.1128/jvi.74.18.8452-8459.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Campbell S, Vogt VM. In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles. J Virol. 1997;71:4425–35. doi: 10.1128/jvi.71.6.4425-4435.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Knejzlík Z, Smékalová Z, Ruml T, Sakalian M. Multimerization of the p12 domain is necessary for Mason-Pfizer monkey virus Gag assembly in vitro. Virology. 2007;365:260–70. doi: 10.1016/j.virol.2007.03.053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Joshi SM, Vogt VM. Role of the Rous sarcoma virus p10 domain in shape determination of gag virus-like particles assembled in vitro and within Escherichia coli. J Virol. 2000;74:10260–8. doi: 10.1128/jvi.74.21.10260-10268.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Phillips JM, Murray PS, Murray D, Vogt VM. A molecular switch required for retrovirus assembly participates in the hexagonal immature lattice. EMBO J. 2008;27:1411–20. doi: 10.1038/emboj.2008.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Nandhagopal N, Simpson AA, Johnson MC, Francisco AB, Schatz GW, Rossmann MG, Vogt VM. Dimeric rous sarcoma virus capsid protein structure relevant to immature Gag assembly. J Mol Biol. 2004;335:275–82. doi: 10.1016/j.jmb.2003.10.034. [DOI] [PubMed] [Google Scholar]
- 75.Vogt VM. Retroviral virions and genomes. In: Coffin JM, Hughes SH, Varmus HE, editors. Retroviruses. Cold Spring Harbor Laboratory Press; NewYork: 1997. pp. 27–70. [PubMed] [Google Scholar]
- 76.Ganser-Pornillos BK, von Schwedler UK, Stray KM, Aiken C, Sundquist WI. Assembly properties of the human immunodeficiency virus type 1 CA protein. J Virol. 2004;78:2545–52. doi: 10.1128/JVI.78.5.2545-2552.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Butan C, Winkler DC, Heymann JB, Craven RC, Steven AC. RSV capsid polymorphism correlates with polymerization efficiency and envelope glycoprotein content: implications that nucleation controls morphogenesis. J Mol Biol. 2008;376:1168–81. doi: 10.1016/j.jmb.2007.12.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Ganser BK, Li S, Klishko VY, Finch JT, Sundquist WI. Assembly and analysis of conical models for the HIV-1 core. Science. 1999;283:80–3. doi: 10.1126/science.283.5398.80. [DOI] [PubMed] [Google Scholar]
- 79.Jin Z, Jin L, Peterson DL, Lawson CL. Model for lentivirus capsid core assembly based on crystal dimers of EIAV p26. J Mol Biol. 1999;286:83–93. doi: 10.1006/jmbi.1998.2443. [DOI] [PubMed] [Google Scholar]
- 80.Li S, Hill CP, Sundquist WI, Finch JT. Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature. 2000;407:409–13. doi: 10.1038/35030177. [DOI] [PubMed] [Google Scholar]
- 81.Heymann JB, Butan C, Winkler DC, Craven RC, Steven AC. Irregular and semi-regular polyhedral models for Rous sarcoma virus cores. Comput Math Methods Med. 2008;9:197–210. doi: 10.1080/17486700802168106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Ivanov D, Tsodikov OV, Kasanov J, Ellenberger T, Wagner G, Collins T. Domain-swapped dimerization of the HIV-1 capsid C-terminal domain. Proc Natl Acad Sci U S A. 2007;104:4353–8. doi: 10.1073/pnas.0609477104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Byeon IJ, Meng X, Jung J, Zhao G, Yang R, Ahn J, Shi J, Concel J, Aiken C, Zhang P, Gronenborn AM. Structural convergence between cryo-EM and NMR reveals intersubunit interactions critical for HIV-1 capsid function. Cell. 2009;139:780–90. doi: 10.1016/j.cell.2009.10.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Bartonova V, Igonet S, Sticht J, Glass B, Habermann A, Vaney MC, Sehr P, Lewis J, Rey FA, Kräusslich HG. Residues in the HIV-1 capsid assembly inhibitor binding site are essential for maintaining the assembly-competent quaternary structure of the capsid protein. J Biol Chem. 2008;283:32024–33. doi: 10.1074/jbc.M804230200. [DOI] [PubMed] [Google Scholar]
- 85.Briggs JA, Wilk T, Welker R, Kräusslich HG, Fuller SD. Structural organization of authentic, mature HIV-1 virions and cores. EMBO J. 2003;22:1707–15. doi: 10.1093/emboj/cdg143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Ehrlich LS, Agresta BE, Carter CA. Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro. J Virol. 1992;66:4874–83. doi: 10.1128/jvi.66.8.4874-4883.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Campbell S, Vogt VM. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J Virol. 1995;69:6487–97. doi: 10.1128/jvi.69.10.6487-6497.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Gross I, Hohenberg H, Kräusslich HG. In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus. Eur J Biochem. 1997;249:592–600. doi: 10.1111/j.1432-1033.1997.t01-1-00592.x. [DOI] [PubMed] [Google Scholar]
- 89.Kingston RL, Fitzon-Ostendorp T, Eisenmesser EZ, Schatz GW, Vogt VM, Post CB, Rossmann MG. Structure and self-association of the Rous sarcoma virus capsid protein. Structure. 2000;8:617–28. doi: 10.1016/s0969-2126(00)00148-9. [DOI] [PubMed] [Google Scholar]
- 90.Purdy JG, Flanagan JM, Ropson IJ, Rennoll-Bankert KE, Craven RC. Critical role of conserved hydrophobic residues within the major homology region in mature retroviral capsid assembly. J Virol. 2008;82:5951–61. doi: 10.1128/JVI.00214-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Cardone G, Purdy JG, Cheng N, Craven RC, Steven AC. Visualization of a missing link in retrovirus capsid assembly. Nature. 2009;457:694–8. doi: 10.1038/nature07724. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Hyun JK, Radjainia M, Kingston RL, Mitra AK. Proton-driven assembly of the Rous Sarcoma virus capsid protein results in the formation of icosahedral particles. J Biol Chem. 2010;285:15056–64. doi: 10.1074/jbc.M110.108209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Bowzard JB, Wills JW, Craven RC. Second-site suppressors of Rous sarcoma virus Ca mutations: evidence for interdomain interactions. J Virol. 2001;75:6850–6. doi: 10.1128/JVI.75.15.6850-6856.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Pornillos O, Ganser-Pornillos BK, Yeager M. Atomic-level modelling of the HIV capsid. Nature. 2011;469:424–7. doi: 10.1038/nature09640. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Mortuza GB, Haire LF, Stevens A, Smerdon SJ, Stoye JP, Taylor IA. High-resolution structure of a retroviral capsid hexameric amino-terminal domain. Nature. 2004;431:481–5. doi: 10.1038/nature02915. [DOI] [PubMed] [Google Scholar]
- 96.Caspar DL, Klug A. Physical principles in the construction of regular viruses. Cold Spring Harb Symp Quant Biol. 1962;27:1–24. doi: 10.1101/sqb.1962.027.001.005. [DOI] [PubMed] [Google Scholar]
- 97.Khorasanizadeh S, Campos-Olivas R, Summers MF. Solution structure of the capsid protein from the human T-cell leukemia virus type-I. J Mol Biol. 1999;291:491–505. doi: 10.1006/jmbi.1999.2986. [DOI] [PubMed] [Google Scholar]
- 98.Campos-Olivas R, Newman JL, Summers MF. Solution structure and dynamics of the Rous sarcoma virus capsid protein and comparison with capsid proteins of other retroviruses. J Mol Biol. 2000;296:633–49. doi: 10.1006/jmbi.1999.3475. [DOI] [PubMed] [Google Scholar]
- 99.Mortuza GB, Goldstone DC, Pashley C, Haire LF, Palmarini M, Taylor WR, Stoye JP, Taylor IA. Structure of the capsid amino-terminal domain from the betaretrovirus, Jaagsiekte sheep retrovirus. J Mol Biol. 2009;386:1179–92. doi: 10.1016/j.jmb.2008.10.066. [DOI] [PubMed] [Google Scholar]
- 100.Bailey GD, Hyun JK, Mitra AK, Kingston RL. Proton-linked dimerization of a retroviral capsid protein initiates capsid assembly. Structure. 2009;17:737–48. doi: 10.1016/j.str.2009.03.010. [DOI] [PubMed] [Google Scholar]
- 101.Purdy JG, Flanagan JM, Ropson IJ, Craven RC. Retroviral capsid assembly: a role for the CA dimer in initiation. J Mol Biol. 2009;389:438–51. doi: 10.1016/j.jmb.2009.04.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Alcaraz LA, del Álamo M, Barrera FN, Mateu MG, Neira JL. Flexibility in HIV-1 assembly subunits: solution structure of the monomeric C-terminal domain of the capsid protein. Biophys J. 2007;93:1264–76. doi: 10.1529/biophysj.106.101089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Ternois F, Sticht J, Duquerroy S, Kräusslich HG, Rey FA. The HIV-1 capsid protein C-terminal domain in complex with a virus assembly inhibitor. Nat Struct Mol Biol. 2005;12:678–82. doi: 10.1038/nsmb967. [DOI] [PubMed] [Google Scholar]
- 104.Wong HC, Shin R, Krishna NR. Solution structure of a double mutant of the carboxy-terminal dimerization domain of the HIV-1 capsid protein. Biochemistry. 2008;47:2289–97. doi: 10.1021/bi7022128. [DOI] [PubMed] [Google Scholar]












